• Provider Compendium
    Aug. 22, 2025

    The increasing adoption of AI, generative AI, analytics, and industry-specific solutions across drug development, commercialization, and regulatory compliance is driving the rapid growth of digital services in the life sciences sector. Enterprises are turning to these…
  • PEAK Matrix®
    June 02, 2025

    Life sciences enterprises are embracing digital technologies to navigate the growing complexities in drug development, commercialization, and regulatory compliance. As economic pressures and competitive dynamics intensify, organizations are turning to digital services to improve operational resilience…
  • Provider Compendium
    Dec. 20, 2022

    Revenue Cycle Management (RCM) platforms facilitate the management of administrative and clinical functions, such as claims processing, payment, and revenue generation, for healthcare facilities. Healthcare organizations are increasingly evaluating RCM platform providers based on the IT…
  • PEAK Matrix®
    Nov. 22, 2022

    Revenue Cycle Management (RCM) platforms facilitate the management of administrative and clinical functions, such as claims processing, payment, and revenue generation, for healthcare facilities. Healthcare organizations are increasingly evaluating RCM platform providers based on the IT…
  • Provider Compendium
    Nov. 21, 2022

    The pandemic necessitated and accelerated the rapid adoption of digital services across the Life Sciences (LS) value chain. As a result, there has been a shift in enterprise mindset to become more customer-centric and invest in…
  • PEAK Matrix®
    Sep. 27, 2022

    The pandemic necessitated and accelerated the rapid adoption of digital services across the Life Sciences (LS) value chain. Therefore, there has been a conscious shift in enterprise mindset to focus on delivering products and services in…
  • Provider Compendium
    Feb. 12, 2021

    The Life Sciences (LS) industry has been at the forefront of the COVID-19 response, ranging from carrying out drug trials and vaccine development to producing Personal Protective Equipment (PPE) and ventilators. There has also been a…
  • PEAK Matrix®
    Dec. 10, 2020

    The Life Sciences (LS) industry has been at the forefront of the COVID-19 response, from carrying out drug trials and vaccine development to producing Personal Protective Equipment (PPE) and ventilators. The industry was already growing significantly…
  • State of the Market
    March 04, 2020

    Now more than ever, the healthcare provider industry is expected to improve care outcomes, keep pace with changing regulatory policies, and stay competitive in the face of disruptions, all the while keeping healthcare costs in check.…
  • PEAK Matrix®
    Dec. 20, 2019

    The payer industry is facing several issues such as escalating costs, declining margins, widespread regulatory amendments, shift from volume- to value-based care model, and rising consumerism. Digital adoption is influencing all aspects of the payer value…
  • PEAK Matrix®
    Sep. 13, 2019

    The life sciences industry is plagued by issues such as high time-to-market for drugs and high costs of drug development. Enterprises have prioritized digital technologies in their corporate strategies to optimize processes, reduce costs, and positively…